Immunomodulatory Effects of IL-12 on Allergic Lung Inflammation Depend on Timing of Doses

Sanjiv Sur, Johnsimon Lam, Page Bouchard, Anastasia Sigounas, Donald Holbert, W. James Metzger

Research output: Contribution to journalArticle

132 Citations (Scopus)

Abstract

We investigated the effects of IL-12 on a murine model of allergic lung inflammation. Administration of IL-12 was timed to interfere with either allergic sensitization (early dosage) or the hypersensitivity inflammatory response in the lung (late dosage), or both (early and late dosages). Comparisons of IL-12- and PBS-treated animals within each treatment group revealed several noticeable effects of IL-12. Early dosage, and the combination of early and late dosages, strikingly decreased ragweed-specific serum IgE, tracheal ring reactivity to acetylcholine, and BAL eosinophilia following allergen challenge. In contrast, late dosage had no effect on IgE levels and only a minimal effect on tracheal ring reactivity, but had a modest effect on recruitment of eosinophils. Early dosage down-regulated IL-5 and IL-10, but did not alter IL-4 or IFN-γ expression. Late dosage down-regulated IL-5, up-regulated IL-10 and IFN-γ, but did not change IL-4 expression. The combination of early and late dosage down-regulated IL-4, IL-5, and IL-10 expression, but increased IFN-γ expression and production in the BAL cells and fluids. Taken together, these results indicate that IL-12 has potent immunomodulatory effects on allergic lung inflammation that depend on the timing of IL-12 administration relative to allergic sensitization and allergen challenge.

Original languageEnglish (US)
Pages (from-to)4173-4180
Number of pages8
JournalJournal of Immunology
Volume157
Issue number9
StatePublished - Nov 1 1996
Externally publishedYes

Fingerprint

Interleukin-12
Pneumonia
Interleukin-5
Interleukin-4
Interleukin-10
Dimercaprol
Allergens
Immunoglobulin E
Ambrosia
Eosinophilia
Eosinophils
Acetylcholine
Hypersensitivity
Lung
Serum

ASJC Scopus subject areas

  • Immunology

Cite this

Sur, S., Lam, J., Bouchard, P., Sigounas, A., Holbert, D., & Metzger, W. J. (1996). Immunomodulatory Effects of IL-12 on Allergic Lung Inflammation Depend on Timing of Doses. Journal of Immunology, 157(9), 4173-4180.

Immunomodulatory Effects of IL-12 on Allergic Lung Inflammation Depend on Timing of Doses. / Sur, Sanjiv; Lam, Johnsimon; Bouchard, Page; Sigounas, Anastasia; Holbert, Donald; Metzger, W. James.

In: Journal of Immunology, Vol. 157, No. 9, 01.11.1996, p. 4173-4180.

Research output: Contribution to journalArticle

Sur, S, Lam, J, Bouchard, P, Sigounas, A, Holbert, D & Metzger, WJ 1996, 'Immunomodulatory Effects of IL-12 on Allergic Lung Inflammation Depend on Timing of Doses', Journal of Immunology, vol. 157, no. 9, pp. 4173-4180.
Sur S, Lam J, Bouchard P, Sigounas A, Holbert D, Metzger WJ. Immunomodulatory Effects of IL-12 on Allergic Lung Inflammation Depend on Timing of Doses. Journal of Immunology. 1996 Nov 1;157(9):4173-4180.
Sur, Sanjiv ; Lam, Johnsimon ; Bouchard, Page ; Sigounas, Anastasia ; Holbert, Donald ; Metzger, W. James. / Immunomodulatory Effects of IL-12 on Allergic Lung Inflammation Depend on Timing of Doses. In: Journal of Immunology. 1996 ; Vol. 157, No. 9. pp. 4173-4180.
@article{4cb24e750e3d4964bc4d79e3d98ba689,
title = "Immunomodulatory Effects of IL-12 on Allergic Lung Inflammation Depend on Timing of Doses",
abstract = "We investigated the effects of IL-12 on a murine model of allergic lung inflammation. Administration of IL-12 was timed to interfere with either allergic sensitization (early dosage) or the hypersensitivity inflammatory response in the lung (late dosage), or both (early and late dosages). Comparisons of IL-12- and PBS-treated animals within each treatment group revealed several noticeable effects of IL-12. Early dosage, and the combination of early and late dosages, strikingly decreased ragweed-specific serum IgE, tracheal ring reactivity to acetylcholine, and BAL eosinophilia following allergen challenge. In contrast, late dosage had no effect on IgE levels and only a minimal effect on tracheal ring reactivity, but had a modest effect on recruitment of eosinophils. Early dosage down-regulated IL-5 and IL-10, but did not alter IL-4 or IFN-γ expression. Late dosage down-regulated IL-5, up-regulated IL-10 and IFN-γ, but did not change IL-4 expression. The combination of early and late dosage down-regulated IL-4, IL-5, and IL-10 expression, but increased IFN-γ expression and production in the BAL cells and fluids. Taken together, these results indicate that IL-12 has potent immunomodulatory effects on allergic lung inflammation that depend on the timing of IL-12 administration relative to allergic sensitization and allergen challenge.",
author = "Sanjiv Sur and Johnsimon Lam and Page Bouchard and Anastasia Sigounas and Donald Holbert and Metzger, {W. James}",
year = "1996",
month = "11",
day = "1",
language = "English (US)",
volume = "157",
pages = "4173--4180",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "9",

}

TY - JOUR

T1 - Immunomodulatory Effects of IL-12 on Allergic Lung Inflammation Depend on Timing of Doses

AU - Sur, Sanjiv

AU - Lam, Johnsimon

AU - Bouchard, Page

AU - Sigounas, Anastasia

AU - Holbert, Donald

AU - Metzger, W. James

PY - 1996/11/1

Y1 - 1996/11/1

N2 - We investigated the effects of IL-12 on a murine model of allergic lung inflammation. Administration of IL-12 was timed to interfere with either allergic sensitization (early dosage) or the hypersensitivity inflammatory response in the lung (late dosage), or both (early and late dosages). Comparisons of IL-12- and PBS-treated animals within each treatment group revealed several noticeable effects of IL-12. Early dosage, and the combination of early and late dosages, strikingly decreased ragweed-specific serum IgE, tracheal ring reactivity to acetylcholine, and BAL eosinophilia following allergen challenge. In contrast, late dosage had no effect on IgE levels and only a minimal effect on tracheal ring reactivity, but had a modest effect on recruitment of eosinophils. Early dosage down-regulated IL-5 and IL-10, but did not alter IL-4 or IFN-γ expression. Late dosage down-regulated IL-5, up-regulated IL-10 and IFN-γ, but did not change IL-4 expression. The combination of early and late dosage down-regulated IL-4, IL-5, and IL-10 expression, but increased IFN-γ expression and production in the BAL cells and fluids. Taken together, these results indicate that IL-12 has potent immunomodulatory effects on allergic lung inflammation that depend on the timing of IL-12 administration relative to allergic sensitization and allergen challenge.

AB - We investigated the effects of IL-12 on a murine model of allergic lung inflammation. Administration of IL-12 was timed to interfere with either allergic sensitization (early dosage) or the hypersensitivity inflammatory response in the lung (late dosage), or both (early and late dosages). Comparisons of IL-12- and PBS-treated animals within each treatment group revealed several noticeable effects of IL-12. Early dosage, and the combination of early and late dosages, strikingly decreased ragweed-specific serum IgE, tracheal ring reactivity to acetylcholine, and BAL eosinophilia following allergen challenge. In contrast, late dosage had no effect on IgE levels and only a minimal effect on tracheal ring reactivity, but had a modest effect on recruitment of eosinophils. Early dosage down-regulated IL-5 and IL-10, but did not alter IL-4 or IFN-γ expression. Late dosage down-regulated IL-5, up-regulated IL-10 and IFN-γ, but did not change IL-4 expression. The combination of early and late dosage down-regulated IL-4, IL-5, and IL-10 expression, but increased IFN-γ expression and production in the BAL cells and fluids. Taken together, these results indicate that IL-12 has potent immunomodulatory effects on allergic lung inflammation that depend on the timing of IL-12 administration relative to allergic sensitization and allergen challenge.

UR - http://www.scopus.com/inward/record.url?scp=0030293642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030293642&partnerID=8YFLogxK

M3 - Article

C2 - 8892655

AN - SCOPUS:0030293642

VL - 157

SP - 4173

EP - 4180

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 9

ER -